TABLE 2.
Performance of 3MRSV by subject group and sample type
| Parameter | Value fora: |
|||||
|---|---|---|---|---|---|---|
| Nasal washes/aspirates |
Nasopharyngeal aspirates |
Nasopharyngeal swabs |
||||
| Group 1 | Group 2 | Group 1 | Group 2 | Group 1 | Group 2 | |
| No. tested | 262 | 246 | 519 | 503 | 525 | 391 |
| Sensitivity, % (95% CI) | 89.1 (0.819-0.936) | 89.9 (0.828-0.943) | 85.4 (0.799-0.897) | 85.3 (0.797-0.896) | 85.8 (0.789-0.907) | 88.2 (0.814-0.927) |
| Specificity, % (95% CI) | 94.1 (0.891-0.969) | 93.4 (0.880-0.965) | 95.3 (0.924-0.971) | 95.1 (0.921-0.970) | 96.9 (0.947-0.982) | 97.4 (0.946-0.987) |
| PPV, % | 91.6 | 91.6 | 91.9 | 91.8 | 90.6 | 94.1 |
| NPV, % | 92.3 | 92.1 | 91.3 | 90.9 | 95.2 | 94.5 |
a
Group 1, subjects of all ages; group 2, subjects <22 years old (age group FDA cleared for 3MRSV testing).